Metraipolis › archive › dc_98818554ea7b
Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors — Europe PMC PMID:41257021
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41257021
- DOI
- 10.1021/acsmedchemlett.5c00467
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T01:09:10.280Z
- SHA-256 of the archived text
314f2682a2eedfd28d3e945cb2ab8a90d62349a192cf7bbba63258248760232f- Stable URL of this page
https://metraipolis.com/documento/dc_98818554ea7b
How to cite
Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors — Europe PMC PMID:41257021 — Europe PMC (en), https://europepmc.org/article/MED/41257021 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98818554ea7b (Metraipolis archive dc_98818554ea7b, sha256 314f2682a2eedfd28d3e945cb2ab8a90d62349a192cf7bbba63258248760232f)
BibTeX
@misc{dc98818554ea7b,
title = {Development of Purine and Pyrrolopyrimidine Scaffolds as Potent, Selective, and Brain Penetrant NUAK1 Inhibitors — Europe PMC PMID:41257021},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41257021},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98818554ea7b; sha256 314f2682a2eedfd28d3e945cb2ab8a90d62349a192cf7bbba63258248760232f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41257021. Agents can read the archived copy with the MCP tool read_document.